National conference on drug abuse in minority communities

September 24, 2001

On September 24-26, the National Institute on Drug Abuse (NIDA) will host "Bridging Science and Culture to Improve Drug Abuse Research in Minority Communities" at the Wyndham Franklin Plaza Hotel in Philadelphia, PA. The conference will bring together researchers, students, academicians, health care providers, and community leaders interested in improving drug abuse research and expanding opportunities for minorities in this field.

"Despite notable progress in the overall health of the Nation, there are continuing disparities experienced by a variety of ethnic and racial minorities, including blacks, Hispanics, American Indians, Alaska Natives, and Pacific Islanders, as compared to the U.S. population as a whole," says NIDA Director Dr. Alan I. Leshner. "This conference provides a unique forum for minorities and non-minorities at every level to collaborate in developing culturally meaningful approaches for understanding and addressing disparities in drug abuse research, prevention, and treatment."

The conference will feature plenary sessions on research findings in prevention, treatment and epidemiology, and the interaction of culture, race, ethnicity,and science on drug abuse research in minority communities. In addition, sessions will also address spirituality, challenges found by minority researchers, and pharmacological and behavioral treatment with minority clients.
An agenda for the conference and more information is available on NIDA's Web site at To register visit NIDA's Web site, or call 301-468-6008, extension 405.

NIH/National Institute on Drug Abuse

Related Drug Abuse Articles from Brightsurf:

Job skills training leads to long-term reduction in drug abuse
Job skills training for low-income youth does more than just help them get better jobs - it makes them significantly less likely than others to use some illicit drugs, even 16 years later.

Drug reduces the risk of child sexual abuse
A drug that lowers levels of the male hormone testosterone in the body reduces the risk of men with pedophilic disorder sexually abusing children, a study from Karolinska Institutet published today in the journal JAMA Psychiatry shows.

Recovery from sperm suppression due to performance-enhancing drug abuse is slow
Decreased sperm and testosterone production caused by abuse of performing-enhancing hormones may be fully reversible once men stop taking the drugs, but full recovery can take at least nine to 18 months, according to research to be presented Sunday, March 24 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

URI drug study produces 'promising therapy' for alcohol abuse
A University of Rhode Island College of Pharmacy professor is working to change that, and a new clinical trial is right around the corner.

Parental attention can reduce risk of drug abuse in adolescence
Survey of more than 6,000 teenagers performed by Brazilian researchers reinforces protective function of rule-keeping, which relies on open dialogue about the importance of rules as much as on children's monitoring.

ADHD medication tied to lower risk for alcohol, drug abuse in teens and adults
The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study published in the American Journal of Psychiatry and led by Indiana University.

Stopping drug abuse can reverse related heart damage
Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical treatment, potentially preventing future drug-related cases of heart failure or other worse outcomes, according to a study published today in JACC: Heart Failure.

Opioid abuse drops when doctors check patients' drug history
There's a simple way to reduce the opioid epidemic gripping the country, according to new Cornell University research: Make doctors check their patients' previous prescriptions.

Alcohol abuse drug can be repurposed to treat a blinding disorder
Disulfiram prevents scars forming in a mouse model of scarring conjunctivitis.

Prescription drug abuse in Europe is a bigger problem than previously thought
International collaborations across the EU are needed to monitor prescription drug abuse, identify its scope and develop targeted interventions, according to the first comparative study of prescription drug abuse in the European Union.

Read More: Drug Abuse News and Drug Abuse Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to